US 12083141
Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors
granted A61KA61K31/7105A61K33/30
Quick answer
US patent 12083141 (Treatment of hyperglycemia with solute carrier family 39 member 5 (SLC39A5) inhibitors) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/7105, A61K33/30